Kidney Function and Failure Study Notes

Overview of Kidney Function and Failure

  • Kidney failure can lead to serious health issues in the body, including fluid overload, electrolyte imbalances (e.g., hyperkalemia), accumulation of toxins (uremia), anemia, and bone disorders, all of which significantly impact systemic health.

  • No new drug prototyping related to kidney function is scheduled for the upcoming module, indicating a potential shift in focus for the curriculum.

Exam 2 Preparation

  • The majority of pharmacologic content pertinent to Exam 2 has already been covered, particularly topics related to basic renal pharmacology and drug excretion.

  • This module will specifically focus on identifying harmful drugs (nephrotoxins) and understanding the mechanisms by which they induce kidney injury, emphasizing clinical toxicology and protective measures.

  • Students will not be prototyping drugs in this module; the emphasis will be on theoretical understanding and practical clinical application of existing knowledge.

Class Schedule Adjustments

  • Class content will be streamlined and delivered in a more focused manner to adapt to a missing Thursday session. This means a concentrated approach on critical topics to ensure essential concepts are covered efficiently.

  • Content from this module, including the mechanisms of kidney injury and nephrotoxic drugs, is included in Exam 2, with a strong emphasis on essential knowledge requirements for diagnosis, management, and prevention of renal complications.

Kidney Physiology

Primary Functions of the Kidneys

  • Kidney roles include three main functions:

    • Filtration

    • Excretes unnecessary components from blood, primarily metabolic waste products such as urea, creatinine, and uric acid, along with excess electrolytes and water.

    • Reabsorbs essential substances back into circulation, including water, electrolytes (sodium, potassium, bicarbonate), glucose, and amino acids, ensuring the body maintains critical nutrient and fluid balance. This occurs primarily in the renal tubules.

    • Regulation

    • Balances fluid and electrolytes by precisely adjusting the excretion and reabsorption of water, sodium, potassium, calcium, and phosphate, thereby maintaining plasma volume and osmolality.

    • Controls acid-base balance by excreting hydrogen ions and reabsorbing bicarbonate, crucial for maintaining optimal pH levels in the blood.

    • Endocrine Functions

    • Secretes renin in response to decreased blood pressure or low sodium levels, initiating the Renin-Angiotensin-Aldosterone System (RAS) for blood pressure regulation.

    • Stimulates red blood cell production via erythropoietin, secreted in response to hypoxia, which acts on the bone marrow to increase erythrocyte synthesis.

    • Ensures proper bone mineral density through the activation of Vitamin D (calcitriol) and regulation of parathyroid hormone (PTH), impacting calcium and phosphate homeostasis.

Key Assessments for Kidney Function

  • Essential tests for assessing kidney health include:

    • Urinalysis

    • Observes urine concentration (specific gravity) and components to provide insights into renal function and potential pathologies.

    • Specific Gravity:

      • Higher than 1.011.01 indicates concentrated urine, often due to dehydration or the kidney's attempt to conserve fluid.

      • Lower indicates diluted urine, which can suggest overhydration or impaired concentrating ability of the kidneys.

    • Cells and Substances in Urine:

      • Proteins: Presence (proteinuria) can indicate glomerular damage.

      • Glucose: Suggests hyperglycemia (diabetes mellitus) once renal threshold is exceeded.

      • Cellular byproducts (ketones): Indicate uncontrolled diabetes or starvation.

      • Nitrites and leukocyte esterase: Are markers for urinary tract infections (UTIs).

      • Cell casts: Aggregates of cells or cellular debris that form in renal tubules, indicating specific types of nephron health issues or injuries (e.g., red blood cell casts for glomerulonephritis, white blood cell casts for pyelonephritis, muddy brown casts for acute tubular necrosis).

    • Urinalysis can visually indicate concentrations, e.g., darker urine indicates higher concentration, whereas visible blood indicates gross hematuria. Other visual cues include cloudy urine (infection) or foamy urine (proteinuria).

    • Blood Tests:

    • Serum Creatinine & Blood Urea Nitrogen (BUN):

      • Increased levels of both indicate decreased filtering efficiency of the kidneys; they are inversely related to GFR.

      • Creatinine is a metabolic byproduct of muscle metabolism, produced at a relatively constant rate. BUN specifically reflects protein metabolism and is also influenced by hydration status and protein intake.

    • Creatinine Clearance (GFR):

      • Measures the filtration speed in the kidneys (glomerular filtration rate) and is considered the best overall index of kidney function. It can be estimated using formulas like Cockcroft-Gault, MDRD, or CKD-EPI equations.

      • There is an inverse relationship with increasing serum creatinine and BUN levels; a doubling of serum creatinine roughly indicates about a 50%50\% decrease in GFR.

    • Imaging Techniques:

    • Ultrasound, CT scans, angiography, or biopsies are utilized to assess kidney structure, size, presence of obstructions (e.g., stones, tumors), or to identify underlying parenchymal disease and scarring when necessary.

  • Key Terms:

    • Azotemia: An asymptomatic laboratory finding characterized by increased BUN and creatinine in the blood, primarily indicating impaired kidney function without systemic symptoms.

    • Uremia: The clinical manifestations associated with azotemia, where accumulated nitrogenous waste products and toxins lead to systemic symptoms such as nausea, vomiting, fatigue, pruritus (itching), loss of appetite, and altered mental status.

    • Oliguria: Reduced urine output, typically defined as less than 400400 ccs/day (or less than 0.50.5 mL/kg/hr for adults over a 66-hour period).

    • Anuria: Minimal to no urine output, typically defined as less than 100100 ccs/day (or less than 5050 mL/day for adults), often indicative of severe kidney injury or obstruction.

Types of Kidney Injuries

Overview of Acute Kidney Injury (AKI)

  • Acute Kidney Injury refers to a sudden and rapid decline in kidney function, often occurring within hours to days. It is characterized by an acute rise in serum creatinine and/or a decrease in urine output, and can be reversible if identified and treated promptly.

  • Diagnostic criteria often include an increase in serum creatinine by ≥0.3\geq 0.3 mg/dL within 4848 hours, or an increase to ≥1.5\geq 1.5 times baseline within 77 days, or urine volume of less than 0.50.5 mL/kg/hr for longer than 66 hours.

  • Three Pathways of Injury:

    1. Prerenal: Caused by inadequate blood flow (perfusion) to the kidneys, leading to decreased GFR without direct kidney damage.

    2. Intrinsic (Intrarenal): Involves direct damage to the kidney tissue itself, specifically the glomeruli, tubules, interstitium, or renal vasculature.

    3. Postrenal: Results from an obstruction of urine flow anywhere along the urinary tract, from the renal pelvis to the urethra, which causes back pressure on the kidneys.

Prerenal Acute Kidney Injury

  • Primarily caused by reduced blood flow or perfusion to the kidneys, leading to decreased GFR. The kidneys themselves are structurally intact initially but are hypoperfused.

    • Causes include: severe hemorrhage, septic shock, hypovolemia (e.g., due to dehydration, severe burns, or excessive diuretic use), heart failure, renal artery stenosis, and liver failure.

  • Urinalysis typically shows concentrated urine with a high specific gravity and minimal protein; hyaline casts may be seen due to the sluggish flow. The kidneys attempt to conserve fluid and sodium.

  • A characteristic increased BUN relative to creatinine (typically greater than a 20:120:1 ratio) is observed due to increased urea reabsorption in the tubules in response to reduced renal perfusion and flow, while creatinine reabsorption remains minimal.

Intrinsic (Intrarenal) Acute Kidney Injury

  • Often results from direct damage to the kidney parenchyma. The most common type is Acute Tubular Necrosis (ATN), but it can also be due to acute interstitial nephritis, acute glomerulonephritis, or vascular injury.

    • Can result from severe or prolonged prerenal injury, leading to ischemic damage to the tubules, or direct nephrotoxic exposure.

  • Elevated creatinine and BUN are observed, but with a more modest ratio (typically 10:110:1 to 15:115:1) compared to prerenal AKI, as both urea and creatinine excretion pathways are impaired proportionally by tubular damage.

  • Urinalysis may reveal key indicators of tubular damage such as muddy brown granular casts, renal tubular epithelial cells, and sometimes white blood cell casts in cases of acute interstitial nephritis or infection. Proteinuria and hematuria can also be present depending on the underlying pathology.

Postrenal Acute Kidney Injury

  • Results from an obstruction of urine flow anywhere from the renal pelvis to the urethra. This back pressure impedes filtration.

    • Causes include: kidney stones, blood clots, tumors (e.g., prostatic, bladder, cervical), benign prostatic hyperplasia (BPH) in men, urethral strictures, neurogenic bladder, or certain medications that cause crystal precipitation.

  • Increased pressure above the obstruction can lead to dilation of the ureter (hydroureter) and renal pelvis/calyces (hydronephrosis), which can cause kidney damage if the obstruction is prolonged. This type of AKI is often reversible if the obstruction is relieved promptly.

Syndromes of Kidney Injury
Nephritic Syndromes

  • Characterized by inflammatory damage to the glomeruli, leading to a decrease in GFR. This inflammation often involves proliferation of glomerular cells and infiltration of leukocytes.

  • Urinalysis findings typically include red blood cells, red blood cell casts (pathognomonic for glomerular inflammation), and potential gross hematuria, in addition to mild to moderate proteinuria, hypertension, and edema.

  • Common causes include post-streptococcal glomerulonephritis, IgA nephropathy, systemic lupus erythematosus, and vasculitis, often detectable following an infection or in the context of systemic autoimmune diseases.

Nephrotic Syndromes

  • Caused by increased permeability of the glomerular capillary wall to proteins, leading to massive proteinuria. The glomeruli are not inflamed, but their filtration barrier is compromised.

  • Urinalysis confirms massive proteinuria ( > 3.5 grams/day for adults), which is the hallmark of the syndrome. This massive protein loss depletes plasma proteins.

  • Edema develops due to severe hypoalbuminemia (low plasma albumin), which reduces plasma oncotic pressure, leading to fluid shifting into the interstitial spaces. Other characteristics include hyperlipidemia and lipiduria, as the liver attempts to compensate for protein loss by increasing lipoprotein synthesis.

Pharmacology and Kidney Function

Nephrotoxic Drugs

  • Drugs that can directly or indirectly harm the kidneys, leading to injury:

    • Pre-Renal Nephrotoxicity:

    • NSAIDs (non-steroidal anti-inflammatory drugs) can constrict the afferent arteriole by inhibiting prostaglandin synthesis, thereby reducing blood flow to the kidneys, worsening perfusion, especially in volume-depleted or elderly patients.

    • ACE inhibitors and ARBs (angiotensin receptor blockers) can cause efferent arteriolar dilation, which reduces glomerular pressure and GFR, particularly in patients with baseline renal impairment or bilateral renal artery stenosis.

    • Intrarenal Nephrotoxicity:

    • Contrast dyes (radiocontrast agents) can cause direct tubular toxicity and medullary ischemia.

    • Certain antibiotics, such as aminoglycosides (e.g., gentamicin) and vancomycin, can accumulate in tubular cells, leading to direct cellular damage.

    • Chemotherapeutic agents (e.g., cisplatin, methotrexate) and immunosuppressants (e.g., cyclosporine, tacrolimus) are also known to cause intrinsic kidney injury through various mechanisms including direct toxicity or interstitial nephritis.

    • Post-Renal Nephrotoxicity:

    • Certain drugs (e.g., methotrexate, acyclovir, sulfonamides, indinavir) can precipitate crystals in the renal tubules or collecting system, leading to obstruction of urine flow and subsequent postrenal AKI.

Chronic Kidney Disease (CKD)

Overview

  • Chronic Kidney Disease is a progressive, irreversible loss of kidney function that develops over months to years. It is characterized by persistent abnormalities in kidney structure or function, often initially asymptomatic, highlighting the importance of early detection and management to slow progression.

  • Common causes include long-standing diabetes mellitus (diabetic nephropathy), uncontrolled hypertension, chronic glomerulonephritis, polycystic kidney disease, and chronic analgesic use.

  • CKD has lasting impacts on various body systems (cardiovascular, musculoskeletal, neurological, hematologic), necessitating careful monitoring and multidisciplinary management to mitigate complications.

Staging CKD by GFR

  • CKD is staged based on the estimated Glomerular Filtration Rate (GFR), reflecting the severity of kidney function decline:

    • Stage 1: GFR ≥90\ge 90 mL/min (with evidence of kidney damage, e.g., proteinuria)

    • Stage 2: GFR 60−8960-89 mL/min (with evidence of kidney damage)

    • Stage 3a: GFR 45−5945-59 mL/min

    • Stage 3b: GFR 30−4430-44 mL/min

    • Stage 4: GFR 15−2915-29 mL/min (severe reduction in GFR)

    • Stage 5: GFR < 15 mL/min or requiring dialysis (End-Stage Renal Disease - ESRD)

Systemic Complications from CKD

  • As kidney function declines, various systemic complications arise:

    • Fluid and electrolyte imbalances: Including hyperkalemia, hyperphosphatemia, hypocalcemia, and metabolic acidosis, due to impaired regulatory functions of the kidneys.

    • Bone mineral disorders: Known as renal osteodystrophy, resulting from calcium/phosphate imbalances, secondary hyperparathyroidism, and impaired Vitamin D activation, leading to bone pain and increased fracture risk.

    • Cardiovascular risk: Significantly elevated, including hypertension, accelerated atherosclerosis, left ventricular hypertrophy, and congestive heart failure, making cardiovascular disease the leading cause of death in CKD patients.

    • Neuropsychological impacts: Such as uremic encephalopathy (confusion, lethargy, seizures) and peripheral neuropathy (tingling, numbness), stemming from the accumulation of uremic toxins.

    • Anemia-related fatigue: Primarily due to decreased erythropoietin production by the damaged kidneys, often compounded by iron deficiency.

Treatment Approaches for CKD

  • Management aims to slow disease progression, manage symptoms, and prevent complications:

    • Erythropoietin-stimulating agents (ESAs) and iron supplementation for anemia management, targeting specific hemoglobin levels to improve energy and quality of life.

    • Phosphate binders: Administered with meals to reduce the intestinal absorption of dietary phosphate, thereby managing hyperphosphatemia.

    • Oral bicarbonate: Used to correct metabolic acidosis, which can otherwise worsen bone disease and protein catabolism.

    • Diuretics: Particularly loop diuretics, are used to manage fluid overload and edema when residual kidney function allows.

    • Potential need for renal replacement therapy: Including hemodialysis or peritoneal dialysis, if kidneys can no longer adequately perform their functions (Stage 5 CKD).

    • Kidney transplants: Represent the most effective long-term solution for end-stage CKD patients, offering improved quality of life and extended survival compared to dialysis.